Acelrx Pharmaceutica (NQ: ACRX )
0.6760 -0.0240 (-3.43%) Streaming Delayed Price Updated: 11:46 AM EDT, Mar 27, 2023 Add to My Watchlist
Press Releases about Acelrx Pharmaceutica
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Long Term Investor Notice: Investigation of Potential Wrongdoing
September 29, 2021
San Diego, CA -- (SBWIRE) -- 09/29/2021 -- Certain directors of AcelRx Pharmaceuticals, Inc. are under investigation concerning potential breaches of fiduciary duties.
NASDAQ: ACRX Investor Notice: Deadline on August 9, 2021 in Lawsuit Against AcelRx Pharmaceuticals, Inc.
July 27, 2021
San Diego, CA -- (SBWIRE) -- 07/27/2021 -- A Deadline is coming up on August 9, 2021 in the lawsuit for certain investors in AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX).
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Investor Notice: Lawsuit Alleges Securities Laws Violations
June 22, 2021
San Diego, CA -- (SBWIRE) -- 06/22/2021 -- An investor, who purchased NASDAQ:ACRX shares, filed a lawsuit over alleged violations of Federal Securities Laws by AcelRx Pharmaceuticals, Inc.
Exposures Financial Legal Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following